New Trends in Cancer for the 21st Century, Volumen 532Antonio Llombart Bosch, Vicente Felipo Springer Science & Business Media, 2003 - 293 páginas Driving the Cell Cycle to Cancer.- Proliferation: The Cell Cycle.- Molecular Analysis of Gene Expression in Tumor Pathology.- Ewing Tumor Biology: Perspectives for Innovative Treatment Approaches.- Cancer Epigenetics: DNA Methylation and Chromatin Alterations in Human Cancer.- Molecular Analysis of Cancer Using DNA and Protein Microarrays.- Proteomic Approaches to the Diagnosis, Treatment, and Monitoring of Cancer.- Structural Basis of Tumoral Angiogenesis.- Matrix Metalloproteinases and Tumor Progression.- Angiogenesis Inhibitors and Their Therapeutic Potentials.- Mutated Tyrosine Kinases as Therapeutic Targets in Myeloid Leukemias.- Targeting PDGF Receptors in Cancer-Rationales and Proof of Concept Clinical Trials.- Immune-Promoted Tumor Cell Invasion and Metastasis. New considerations in cancer therapy.- Improvements of Survival in Nine Phase II Clinical Studies With Different Types of Cancer Upon Anti-Tumor Vaccination with an Autologous Tumor Cell Vaccine Modified by Virus Infection to Introduce Danger Signals.- Causation and Prevention of Solely Estrogen-Induced Oncogenesis: Similarities to Human Ductal Breast Cancer.- Cyclooxygenase-2 Inhibitors in Cancer Prevention and Treatment.- Exosomes for Immunotherapy of Cancer.- Breast Cancer Gene Expression Analysis ¡a The Case for Dynamic Profiling..- Development of the Epidermal Growth Factor Receptor Inhibitor TARCEVATm (OSI-774).- Gefitinib (TRESSA, ZD 1839) for Non-Small Cell Lung Cancer (NSCLC): Recents Results and Further Strategies.- Mechanism of Action of Anti-HER2 Monoclonal Antibodies: Scientific Update on Trastuzumab and 2C4.- EORTC Research and Development: Achievements and Future Perspectives.- Contributors. |
Índice
DRIVING THE CELL CYCLE TO CANCER | 1 |
THE CELL CYCLE | 2 |
PATHOLOGY | 19 |
PERSPECTIVES FOR INNOVATIVE TREATMENT APPROACHES | 27 |
DNA METHYLATION AND CHROMATIN ALTERATIONS IN HUMAN CANCER | 39 |
MOLECULAR ANALYSIS OF CANCER USING DNA AND PROTEIN MICROARRAYS | 51 |
PROTEOMIC APPROACHES TO THE DIAGNOSIS TREATMENT AND MONITORING OF CANCER | 59 |
STRUCTURAL BASIS OF TUMORAL ANGIOGENESIS | 69 |
IMPROVEMENTS OF SURVIVAL IN NINE PHASE II CLINICAL STUDIES WITH DIFFERENT TYPES OF CANCER UPON ANTI TUMOR VAC... | 175 |
SIMILARITIES TO HUMAN DUCTAL BREAST CANCER | 195 |
CYCLOOXYGENASE2 INHIBITORS IN CANCER PREVENTION AND TREATMENT | 209 |
EXOSOMES FOR IMMUNOTHERAPY OF CANCER | 215 |
BREAST CANCER GENE EXPRESSION ANALYSIS The Case For Dynamic Profiling | 223 |
DEVELOPMENT OF THE EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR TARCEVA OSI774 | 235 |
REGENTS RESULTS AND FURTHER STRATEGIES | 247 |
SCIENTIFIC UPDATE ON TRASTUZUMAB AND 2C4 | 253 |
MATRIX METALLOPROTEINASES AND TUMOR PROGRESSION | 91 |
ANGIOGENESIS INHIBITORS AND THEIR THERAPEUTIC POTENTIALS | 109 |
MUTATED TYROSINE KINASES AS THERAPEUTIC TARGETS IN MYELOID LEUKEMIAS | 121 |
TARGETING PDGF RECEPTORS IN CANCER RATIONALES AND PROOF OF CONCEPT CLINICAL TRIALS | 141 |
IMMUNEPROMOTED TUMOR CELL INVASION AND METASTASIS | 153 |
ACHIEVEMENTS AND FUTURE PERSPECTIVES | 269 |
CONTRIBUTORS | 277 |
283 | |
Otras ediciones - Ver todo
New Trends in Cancer for the 21st Century: Proceedings of the International ... Antonio Llombart-Bosch,Vicente Felipo Vista previa restringida - 2012 |
New Trends in Cancer for the 21st Century: Proceedings of the International ... Antonio Llombart-Bosch,Vicente Felipo No hay ninguna vista previa disponible - 2012 |
New Trends in Cancer for the 21st Century Antonio Llombart-Bosch,Vicente Felipo No hay ninguna vista previa disponible - 2003 |
Términos y frases comunes
activity analysis angiogenic angiostatin antibodies antigen antitumor apoptosis BCR-ABL binding Biol blood breast cancer cancer cells cancer patients Cancer Res carcinoma Cdk4 cell cycle cell lines cellular Chem chemotherapy chromosome clinical trials CpG island cyclin dendritic cells disease domain dose drug effects EGFR endothelial cells EORTC ErbB estrogen exosomes expression profiling FLT3 function fusion gefitinib gene expression genetic genomic growth factor receptor hamster HER2 heterodimers human cancer human tumors hypermethylation Immunol induced inhibition interaction invasion kinase inhibitor leukemia levels ligand lung mammary matrix metalloproteinase mechanisms melanoma metastasis metastatic methylation mice microarrays MMPs models molecular molecules mutations myeloid Natl normal oncogene Oncol overexpression pathways PDGF phase phosphorylation Proc proliferation protein proteomics regulation role sarcoma signaling specific studies survival Tarceva target therapeutic therapy tissue transcription transformation trastuzumab treatment tumor cells tumor growth tyrosine kinase vaccine vascular VEGF vessels virus vitro vivo